-
-
-
-
-
-
-
Danaher (DHR) PT Raised to $270 at BofA Securities
-
-
-
-
-
-
-
Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy
-
-
-
-
-
-
-
Danaher (DHR) Tops Q3 EPS by 17c
-
-
-
-
-
-
-
Danaher (DHR) call put ratio 1 call to 1 put into the expected release of results
-
-
-
-
-
-
-
Danaher (DHR) Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
-
-
-
-
-
-
-
Danaher (DHR) PT Lowered to $230 at Jefferies
-
-
-
-
-
-
-
Goldman Sachs Upgrades Danaher (DHR) to Buy
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

